OpenAlex
PricingAboutJobs
Log inGet started
Work

Effect of Muraglitazar on Death and Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes Mellitus

HTML

Year: 2005
Type: article
Source: JAMA
DOI: 10.1001/jama.294.20.joc50147
Authors: Steven E. Nissen, Kathy Wolski, Eric J Topol
Institution: Cleveland Clinic
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: muraglitazar, type 2 diabetes, major adverse cardiovascular events, cardiovascular safety, PPARγ agonists, pioglitazone, myocardial infarction, stroke, congestive heart failure, transient ischemic attack, death, metformin, glibenclamide, FDA advisory committee, drug approval, glycemic control, adverse drug reactions
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2165815833
FWCI: 33.15
Cites: 17
Cited by: 579
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms